News

In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...
We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...
Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...
The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.
Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...
Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.
RFK Jr says Trump calls him 'three of four times a week' to ask why people aren't healthier yet From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story ...
Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...
Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which ...
The Pfizer and Moderna COVID vaccines use mRNA technology to fight the virus. The same technology could lead to a long-desired vaccine for HIV/AIDS.